Tag Archives: Hanmi

Hanmi keeps challenging Pfizer’s Champix in smoking cessation drug market

Hanmi Pharmaceutical has decided not to give up on its anti-nicotine therapy and challenge Pfizer’s original treatment, Champix (ingredient: varenicline tartrate), once again. Hanmi Pharmaceutical is set to continue its challenge for an anti-nicotine therapy with a modified salt base of Pfizer’s original treatment Champix (ingredient: varenicline tartrate). Earlier, the Korean company successfully released a treatment with the modified salt base but failed as it lost in the patent litigation. After the patent expired, Hanmi tried again with a […]

Read more